1 / 43

Vascularitis

Vascularitis. VASCULITIS. Prof Gergely Péter. Active necrotizing vasculitis. Active necrotizing vasculitis. Vasculitic scars. Vasculitic scars. Vasculitis - HE. Vasculitis - HE. Classification of s y st e m ic vasculitis (Fauci et al , 1978).

michi
Download Presentation

Vascularitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Vascularitis VASCULITIS Prof Gergely Péter

  2. Active necrotizing vasculitis Active necrotizing vasculitis

  3. Vasculitic scars Vasculitic scars

  4. Vasculitis - HE Vasculitis - HE

  5. Classification of systemic vasculitis (Fauci et al, 1978) Classification of systemic vasculitis (Fauci et al, 1978) I. Polyarteritis nodosa group 1. Classic polyarteritis nodosa (PAN) 2. allergic granulomatosis (Churg-Strauss syndrome) 3. Overlap forms II. Hypersensitive vasculitis Specialforms: - serum sickness - Henoch Schönlein’s purpura - mixedcryoglobulinemic vasculitis - vasculitis associtade with malignancy - vasculitis associtade with systemic autoimmune diseases III. Wegener’s granulomatosis IV. Lymphomatoid granulomatosis V. Giant cell angiitis 1. temporal arteritis (and polymyalgia rheumatica) 2. Takayasu’s arteritis VI. Other vasculitis 1. Thrombangiitis obliterans (Buerger’s disease) 2. Kawasaki disease

  6. Classification of systemic vasculitis (Chapel Hill Consensus Conference, 1994) • Classification of systemic vasculitis (Chapel Hill Consensus • Conference, 1994) • Large vessel vasculitis: • Giant cell arteritis – vasculitis of aorta and larger branches – mainly on extracranial branches of aorta. • Occurs over 50 ys. Frequently associated with polymyalgia rheumatica • Takayasu’s arteritis – Granulomatous inflammation of aorta and • larger branches. Occurs befora the age of 50 • Medium sized vessel vasculitis • PAN (classic PAN) – necrotizing inflammation of medium sized • or small arteries. Without glomerulonephritis, arteriole, • capillary and venule inflammation • Kawasaki disease • inflammation of large, medium sized and small arteries – • with skin, lymph node and mucous membrane symptoms. • Frequently affects coronaries, occurs mainly in small • children

  7. Small cell vasculitis Small cell vasculitis: Wegener’s granulomatosis necrotizing inflammation primarily of airway vessels, frequently with necrotizing glomerulonephritis Churg-Strauss syndrome - eosinophile granulocytic necrotizing vasculitis, involving vessels of airways microscopic polyangiitis (microscopic polyarteritis) necrotizing inflammation of arterioles, capillaries, venules (may involve also medium sized arteries) pauci-immune (i.e. no IC deposit) frequent necrotizing glomerulonephritis and capillaritis of lungs Henoch-Schönlein’s purpura vasculitis localized to capillaries, venules, arterioles, with IgA deposition, with skin, intestinal and glomerular involvement essential cryoglobulinemic vasculitis cryoglobulin and cryoglobulin deposition cutaneous-leukocytoclastic vasculitis without visceral involvement

  8. Classification criteria of polyarteritis nodosa (ACR, 1990) Classification criteria of polyarteritis nodosa (ACR, 1990) 1 Weight loss 4 kg (since illness began, not due to dieting or other factors) 2 Livedo reticularis (mottled reticular pattern over the skin of portions of extremities or torso) 3 Testicular pain or tenderness (not due to infection, trauma or other causes) 4 Myalgias, weakness, or leg tenderness (diffuse myalgias, excluding shoulder and hip girdle, or weakness of muscles or tenderness of leg muscles) 5 Mono- or polyneuropathy 6 Hypertension (diastolic blood pressure >90 Hgmm) 7 Elevated BUN or creatinine 8 Hepatitis B virus (presence of virus antigen or antibody) 9 Arteriographic abnormality (aneurysms or occlusions of the visceral arteries, not due to other causes, e.g. arteriosclerosis, etc.) 10 Biopsy (granulocytes and/or granulocytes and mononuclear leukocytes in the artery wall) Diagnosis is based on the presence of at least 3 criteria.

  9. Livedo reticularis Livedo reticularis

  10. Livedo vasculitis Livedo vasculitis

  11. Livedo reticularis (racemosa) Livedo reticularis (racemosa)

  12. PAN - aneurysms PAN - aneurysms

  13. Classification criteria of allergic granulomatosis (Churg-Strauss syndrome) (ACR, 1990) Classification criteria of allergic granulomatosis (Churg-Strauss syndrome) (ACR, 1990) 1 Asthma (in the history) 2 Eosinophilia in WBC count (>10%) 3 Mono- or polyneuropathy 4 Non-fixed pulmonary infiltrates (migratory or transitory infiltrates on radiographs) 5 Paranasal sinus abnormality (history of acute or chronic paranasal sinus pain or tenderness or radiographic opacification) 6 Biopsy (artery, arteriole or venule, showing accumulation of eosinophils in extravascular area) Diagnosis is based on the presence of at least 4 criteria.

  14. Churg-Strauss syndrome - tissue eosinophilia Churg-Strauss syndrome - tissue eosinophilia

  15. Classification criteria of Wegener’s granulomatosis (ACR, 1990) Classification criteria of Wegener’s granulomatosis (ACR, 1990) 1 Nasal or oral inflammation (painful or painless oral ulcers or purulentor bloody nasal discharge) 2 Abnormal chest radiograph (presence of nodules, fixed infiltrates, or cavities) 3 Urinary sediment (microhematuria , i.e. >5 red blood cell per high power field, or red cell casts in sediment) 4 Biopsy (granulomatous inflammation within the wall of an artery or in the peri- or extravascular area of artery or arteriole) Diagnosis is based on the presence of at least 2 criteria. In the absence of specific biopsy finding, hemoptysis can be used as a surrogate variable.

  16. Wegener’s granulomatosis - lungs Wegener’s granulomatosis - lungs

  17. Chest X ray in Wegener’s granulomatosis Chest X ray in Wegener’s granulomatosis

  18. Saddle nose deformity in Wegener’s granulomatosis Saddle nose deformity in Wegener’s granulomatosis

  19. Classification criteria of hypersensitivity vasculitis (ACR, 1990) Classification criteria of hypersensitivity vasculitis (ACR, 1990) 1 Age at onset over 16 years 2 Medication at disease onset 3 Palpable purpura (slightly elevated purpuric rash over one or more areas of the skin; does not blench with pressure and is not related to thrombocytopenia) 4 Maculopapular rash (flat or raised lesions of various sizes over one or more areas of the skin) 5 Biopsy (granulocytes in a peri- or extravascular localisation) Diagnosis is based on the presence of at least 3 criteria.

  20. Leukocytoclasis Leukocytoclasis

  21. Cutaneous leukocytoclastic vasculitis Cutaneous leukocytoclastic vasculitis

  22. Cryoglobulinemia Cryoglobulinemia

  23. Cyoglobulinemia - HBsAg+ Cyoglobulinemia - HBsAg+

  24. Vasculitis in RA Vasculitis in RA

  25. Classification criteria of Henoch-Schönlein purpura (ACR, 1990) Classification criteria of Henoch-Schönlein purpura (ACR, 1990) 1 Palpable purpura 2 Age  20 years at disease onset 3 Bowel angina (diffuse abdominal pain, worse after meals, or bloody diarrhea) 4 Biopsy (granulocytes in the walls of arterioles and venules) Diagnosis is based on the presence of at least 2 criteria.

  26. H-S purpura – palpable purpura H-S purpura – palpable purpura

  27. H-S purpura H-S purpura

  28. Classification criteria of giant cell arteritis (temporal arteritis) (ACR, 1990) Classification criteria of giant cell arteritis (temporal arteritis) (ACR, 1990) 1 Age at onset 50 years 2 "New" headache (new onset or new type of localized pain) 3 Temporal artery abnormality (tenderness to palpation or decreased pulsation, unrelated to other causes, e.g. arteriosclerosis) 4 Elevated ESR (50 mm/hr) 5 Abnormal artery biopsy (vasculitis with mononuclear cell infiltration or granulomatous inflammation with multinucleatedgiant cells) Diagnosis is based on the presence of at least 3 criteria.

  29. Arteritis temporalis – giant cells Arteritis temporalis – giant cells

  30. Inflamed, painful arteria temporalis Inflamed, painful arteria temporalis

  31. Angiography in arteritistemporalis Angiography in arteritis temporalis

  32. Diagnostic criteria of polymyalgia rheumatica (Healey, 1984) Diagnostic criteria of polymyalgia rheumatica (Healey, 1984) Absolute criterium: onset after 50 ys of age Other criteria: 1 Neck, shoulder or hip pain 2. Morning stiffness for at least 2 hrs 3 Elevated ESR (>40 mm/hr) 4 Rapid response to low dose corticosteroid <20 mg prednisolone/day) Diagnosis is based on the absolute criteria + 3 others

  33. Classification criteria of Takayasu’s arteritis (ACR, 1990) Classification criteria of Takayasu’s arteritis (ACR, 1990) 1 Onset before 40 ys of age 2 Claudication of extremities (pain or dyscomfort on movement, mostly in upper extremities) 3 Decreased brachial artery pulse (decreased pulsation of one or both brachial arteries) 4 More than 10 mm Hg difference in systolic blood pressure between arms 5 Bruit over subclavian arteri(es) or (abdominal) aorta 6 Arteriogram abnormality (occlusion or narrowing of the aorta, its branches or large arteries, not due to other cause, e.g. arteriosclerosis, etc.) At least 3 criteria are required for a definite diagnosis.

  34. Takayasu’s arteritis Takayasu’s arteritis

  35. Diagnostic criteria of Kawasaki disease (American Heart Association, 1990): Diagnostic criteria of Kawasaki disease (American Heart Association, 1990): 1. Fever, persisting 5 days or more (with no other cause) 2. At least four of the followings: a) Non exudative conjunctival congestion b) Oropharyngeal signs: mucosal erythema, or reddening of lips, or strawberry tongue c) Peripheral extremities: reddening of palms and soles, in-durative edema, membranous desquamation of fingertips d) Polymorphous exanthema e) Acute nonpurulent cervical lymphadenopathy (one or more lymph nodes with at least 1.5 cm diameter) Diagnosis requires at least 4 criteria. In case of coronary involvement and less than 4 criteria, atypical Kawasaki disease diagnosis may be made.

  36. Reddened lips and strawberry tongue in Kawasaki disease Reddened lips and strawberry tongue in Kawasaki disease

  37. Enlarged lymph nodes in Kawasaki disease Enlarged lymph nodes in Kawasaki disease

  38. Membranous desquamation of fingertips in Kawasaki disease Membranous desquamation of fingertips in Kawasaki disease

  39. Classification criteria of Behçet’s syndrome (ISG 1990) Classification criteria of Behçet’s syndrome (ISG 1990) A Recurrent (>3/year) aphthae in the mouth B 1. Recurrent genital ulcers 2. Ocular symptoms (uveitis, retinal vasculitis) 3. Skin symptoms (erythema nodosum, pseudofolliculitis, papulopustular lesions, acneiform nodules) 4. Positive pathergic test (papular/pustular reaction after an aseptic needle prick) Diagnosis = A + 2 B criteria (exclude all other diseases!) Other: aphthous stomatitis, Crohn’s disease, Takayasu’s arteritis, polychondritis.

  40. Oral ulceration - Behcet Oral ulceration - Behcet

  41. Erythema nodosum Erythema nodosum

  42. Therapy 1. Periarteritis (PAN), Wegener’s granulomatosis, and microscopic polyangiitis: Starting with 1-4 mg/kg/day corticosteroid (CS) + 100 mg/day p.o. cyclophospgamide (CTX), followed by CTX monotherapy (generally for 2 years). In case of intolerance, azathioprine (100 mg/day) or methotrexate (MTX) (25 mg/week) adható. In mild Wegener’s co-trimoxazol (Sumetrolim) therapy may be sufficient. 2. Schönlein-Henoch purpura: 0.5-1 mg/kg/day CS. Arthritis will respond to NSAID, long-term prognosis is determined by kidney disease. 3. Cryoglobulinemia: in “idiopathic”, hepatitis C virus positive cases, complex antiviral treatment (interferon-alpha + ribavirin) is required, CS, or CS+azathioprine therapy affects only arthritis and purpura, but not glomerulonephritis.

  43. Therapy (cont’d) Therapy (cont’d) 4. Temporal arteritis: in mild cases 0.5 mg/kg/day CS, or NSAID may be sufficient. In more severe cases 1-2 mg/kg/day CS is recommended. If inflammation last for longer, azathioprine may be added to CS. 5. Polymyalgia rheumatica: In general 0.5 mg/kg/day CS (25 mg/day prednisolon or 20 mg methylprednisolon) is sufficient. 6. Takayasu’s arteritis: only in early active stage: 1 mg/kg/day CS and/or CTX for ½-1 year. In later stage: surgery. 7. Kawasaki betegség: in mild cases NSAID, in case of coronaritis high dose intravenous immune globulin (IVIG) (0.4 mg/kg/dose). 8. Behçet’s syndrome. In skin and mucous membrane involvation: 1-2 mg/kg/day CS, or colchicin, NSAID. In case of uveitis, retina vasculitis 1-2 mg/kg/day CS + 5-6 mg/kg/day cyclosporine! In arthritis NSAID, 1 mg/kg/day CS, azathioprine, or CTX may be required. In thrombophlebitis esetén: heparin, or warfarin.

More Related